Skip to main content
. 2021 Feb 19;9(2):e002015. doi: 10.1136/jitc-2020-002015

Figure 3.

Figure 3

Clinical activity in (A) all response-evaluable patients, (B) mesothelioma, (C) ovarian cancer, and (D) non-small cell lung cancer/other.